The invention relates to a novel composition and method for targeted drug delivery to breast cancer cells, addressing the challenges of conventional cancer therapies. By conjugating the cell-penetrating peptide (CPP) (CR)4 to liposomes encapsulating the chemotherapeutic agent doxorubicin, the invention enables preci...